Vaccine effectiveness of heterologous CoronaVac plus Pfizer in Brazil.
10 Feb, 2022 | 10:01h | UTCVaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil – Nature Medicine
Commentary on Twitter
An analysis of data from Brazil in @NatureMedicine shows that vaccine effectiveness against SARS-CoV-2 infection and severe COVID-19 outcomes declines after two doses of CoronaVac but increases after a booster dose of the Pfizer-BioNTech vaccine. https://t.co/UCgy6cJFIP pic.twitter.com/pXvkxZHXvv
— Nature Portfolio (@NaturePortfolio) February 9, 2022